Share on LinkedInShare on LinkedIn

ARTICLE · 17 JANUARY 2019

Strict Examination Criteria Needed For Drug Patents

Khurana & Khurana, Advocates and IP Attorneys
Explore more from Khurana & Khurana, Advocates and IP Attorneys

Patentability of pharmaceutical drugs and other issue associated with the patent have been a moot point all over the world.

IndiaIntellectual Property

Background

Patentability of pharmaceutical drugs and other issue associated with the patent have been a moot point all over the world. Like other developing countries, India has also started granting patent rights to pharmaceutical drug products since the year 2005. The biggest concern that comes up in this scenario is of 'Ever greening strategies' which are dealt in section 3(d) of the Indian Patent Act, 1970. The said section proscribes the grant of patent to a new form of a known substance unless it substantially enhances the therapeutic efficacy of the drugs. Thus, the need to strike a balance between public rights i.e. drugs accessibility and private rights of innovative companies gets redoubled. Furthermore, 'the standard of therapeutic efficacy' is also a moot point and poses a bigger question to the judiciary and other competent authorities while granting or denying Patent protection.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from